vTv Therapeutics (VTVT) Times Interest Earned (2014 - 2025)
vTv Therapeutics' (VTVT) quarterly Times Interest Earned came in at -$7885.0 in Q4 2025, down 268.49% quarter-over-quarter from -$2139.8 in Q3 2025.
vTv Therapeutics (VTVT) Times Interest Earned (2014 - 2025) Analysis & Trends
vTv Therapeutics has disclosed Times Interest Earned across 11 years of filings, most recently posting -$7885.0 for Q4 2025.
- Times Interest Earned for Q4 2025 came in at -$7885.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$507.0 (changed N/A YoY), and the FY2025 annual result was -$5468.0, changed N/A from the prior year.
- Times Interest Earned came in at -$7885.0 for Q4 2025 at vTv Therapeutics, down from -$2139.8 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$267.17 in Q3 2021 to a low of -$7885.0 in Q4 2025.
- The 4-year median for Times Interest Earned is -$1596.8 (2021), against an average of -$2640.7.
- Across the five-year window, Times Interest Earned tumbled 6878.72% in 2021 and soared 42.9% in 2022, its largest moves.
- vTv Therapeutics' Times Interest Earned stood at -$1851.5 in 2021, then jumped by 42.9% to -$1057.2 in 2022, then surged by 36.39% to -$672.43 in 2023, then tumbled by 1072.62% to -$7885.0 in 2025.
- The last three Times Interest Earned figures came in at -$7885.0 (Q4 2025), -$2139.8 (Q3 2025), and -$672.43 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7,885.00 |
| Sep 30, 2025 | -2,139.80 |
| Dec 31, 2023 | -672.43 |
| Sep 30, 2023 | -1,342.00 |
| Jun 30, 2023 | -4,000.00 |
| Dec 31, 2022 | -1,057.17 |
| Sep 30, 2022 | -711.13 |
| Mar 31, 2022 | -6,481.00 |
| Dec 31, 2021 | -1,851.50 |
| Sep 30, 2021 | -267.17 |
| Dec 31, 2020 | 27.31 |
| Sep 30, 2020 | -12.05 |
| Jun 30, 2020 | -18.94 |
| Mar 31, 2020 | -39.56 |
| Dec 31, 2019 | -22.57 |
| Sep 30, 2019 | -13.43 |
| Jun 30, 2019 | -9.32 |
| Mar 31, 2019 | -6.85 |
| Dec 31, 2018 | -0.47 |
| Sep 30, 2018 | -1.80 |